Used as a key intermediate in the synthesis of varenicline, a medication for smoking cessation. It acts as a selective agonist at α4β2 nicotinic acetylcholine receptors, helping reduce nicotine cravings and withdrawal symptoms. Its chiral structure is essential for optimal receptor binding and pharmacological activity. Commonly employed in pharmaceutical research and development for nicotine addiction treatments.